129
Participants
Start Date
August 31, 2023
Primary Completion Date
August 31, 2024
Study Completion Date
August 31, 2025
moderate-severe or greater (MR ≥ 3+) functional mitral regurgitation (FMR) patients
Functional mitral regurgitation (FMR) is common in patients with myocardial infarction or dilated cardiomyopathy, and portends a poor prognosis despite guideline-directed medical therapy (GDMT).
Yunnan Fuwai Cardiovascular Hospital, Kunming
Lead Sponsor
Jenscare Scientific
INDUSTRY